Search Results

55 Results for "ipsogen".

Sort By

FDA

QIAGEN Wins FDA Nod for First-Ever JAK2 Test for Use in Diagnosis of Additional Myeloproliferative Neoplasms

The approval is for its ipsogen JAK2 RGQ PCR Kit for additional use in the diagnosis of all MPNs.

January 23, 2018
·
1 min read
Business

TrovaGene, Inc., Achieves Intellectual Property Milestone Under License Agreement with Ipsogen

August 29, 2012
·
5 min read
Deals

QIAGEN Inc. Plans to Buy Cancer MDx Firm Ipsogen for $101 Million

June 15, 2011
·
10 min read
Deals

QIAGEN N.V. Reaches Agreement To Buy 61% Stake In Ipsogen, Plans To Fully Acquire Leader In Oncology Molecular Diagnostics

July 11, 2011
·
6 min read
Ipsogen Reinforces its Leadership in Molecular Diagnosis and Monitoring of Leukemia

January 12, 2009
·
2 min read
Business

Ipsogen Confirmation of Strong Growth Over the First Half of 2008

August 1, 2008
·
1 min read
FDA

Ipsogen Announces the CE Marking of its “ProfileQuant(R) WT1" Kit

March 16, 2009
·
2 min read
Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting

July 10, 2009
·
4 min read
QIAGEN’s tuberculosis blood test QuantiFERON-TB Gold Plus gains CE-marking under new EU IVDR framework

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the certification of QuantiFERON-TB Gold Plus (QFT-Plus) – the world’s leading tuberculosis (TB) blood test – under the European Union’s 2017/746 In Vitro Diagnostic Medical Devices Regulation (IVDR) which is replacing the 98/79/EC In Vitro Diagnostic Directive (IVDD).

February 14, 2023
·
4 min read
Business

Ipsogen Consolidates its Position in North America and Appoints Susan Hertzberg President

September 3, 2008
·
2 min read